The results showed that CASP1, NLRP3, AIM2, and NLRP1 exhibited excellent diagnostic efficacy, suggesting their potential utility as diagnostic biomarkers for lung adenocarcinoma. This evidence concerns the gene NLRP3 and lung adenocarcinoma.